EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nuclear translocation of YAP drives BMI ‐associated hepatocarcinogenesis in hepatitis B virus infection

Xufeng Luo, Rui Zhang, Stefan Schefczyk, Yaojie Liang, Shu S Lin, Shi Liu, Hideo A Baba, Christian M Lange iD, Heiner Wedemeyer iD, Mengji Lu iD, Ruth Broering iD

Liver International · 2023

DOI: 10.1111/liv.15628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Xufeng Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Lymphoma Research, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma (HCC) development and progression. The aim of this study was to mechanistically investigate the involvement of Hippo signalling in HBV surface antigen (HBsAg)‐dependent neoplastic transformation.

Methods

Liver tissue and hepatocytes from HBsAg‐transgenic mice were examined for the Hippo cascade and proliferative events. Functional experiments in mouse hepatoma cells included knockdown, overexpression, luciferase reporter assays and chromatin immunoprecipitation. Results were validated in HBV‐related HCC biopsies.

Results

Hepatic expression signatures in HBsAg‐transgenic mice correlated with YAP responses, cell cycle control, DNA damage and spindle events. Polyploidy and aneuploidy occurred in HBsAg‐transgenic hepatocytes. Suppression and inactivation of MST1/2 led to the loss of YAP phosphorylation and the induction of BMI1 expression in vivo and in vitro. Increased BMI1 directly mediated cell proliferation associated with decreased level of p16 INK4a , p19 ARF , p53 and Caspase 3 as well as increased Cyclin D1 and γ‐H2AX expression. Chromatin immunoprecipitation and the analysis of mutated binding sites in dual‐luciferase reporter assays confirmed that the YAP/TEAD4 transcription factor complex bound and activated the Bmi1 promoter. In chronic hepatitis B patients, paired liver biopsies of non‐tumour and tumour tissue indicated a correlation between YAP expression and the abundance of BMI1. In a proof‐of‐concept, treatment of HBsAg‐transgenic mice with YAP inhibitor verteporfin directly suppressed the BMI1‐related cell cycle.

Conclusion

HBV‐associated proliferative HCC might be related to the HBsAg‐YAP‐BMI1 axis and offer a potential target for the development of new therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis BLiver NeoplasmsAnimalsMiceHepatitis B Surface AntigensHepatitis B virusMice, TransgenicProto-Oncogene ProteinsPolycomb Repressive Complex 1YAP-Signaling Proteins

Stichwörter der Autor:innen

BMI1HBV surface antigenYAPchromosomal instabilityhepatocarcinogenesisproliferation

Substanzen

Hepatitis B Surface AntigensBmi1 protein, mouseProto-Oncogene ProteinsPolycomb Repressive Complex 1Yap1 protein, mouseYAP-Signaling Proteins

Autor:innen und Institutionen

  • Institute for Lymphoma Research, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Department of Gastroenterology, Hepatology and Transplant Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
  • Department of Hepato-Pancreato-Biliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, China.
  • Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Internal Medicine II, LMU University Hospital Munich, Munich, Germany.

ORCID-Profile: Christian M Lange, Heiner Wedemeyer, Mengji Lu, Ruth Broering

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Luo, X., Zhang, R., Schefczyk, S., Liang, Y., Lin, S. S., Liu, S., Baba, H. A., Lange, C. M., Wedemeyer, H., Lu, M., & Broering, R. (2023). Nuclear translocation of YAP drives BMI ‐associated hepatocarcinogenesis in hepatitis B virus infection. Liver International. https://doi.org/10.1111/liv.15628

Vancouver

Luo X, Zhang R, Schefczyk S, Liang Y, Lin SS, Liu S, et al. Nuclear translocation of YAP drives BMI ‐associated hepatocarcinogenesis in hepatitis B virus infection. Liver International. 2023. doi:10.1111/liv.15628

BibTeX
@article{Luo2023,
  author = {Luo, Xufeng and Zhang, Rui and Schefczyk, Stefan and Liang, Yaojie and Lin, Shu S and Liu, Shi and Baba, Hideo A and Lange, Christian M and Wedemeyer, Heiner and Lu, Mengji and Broering, Ruth},
  title = {Nuclear translocation of YAP drives BMI ‐associated hepatocarcinogenesis in hepatitis B virus infection},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15628}
}
Kostenlos starten →